Complete Genomics

Latest Headlines

Latest Headlines

BGI slams brakes on Revolocity rollout, lays off staff in business rethink

BGI has slammed the brakes on the rollout of the population-scale sequencing system that was set to offer an alternative to Illumina's HiSeq X platform, GenomeWeb reports. The setback is part of a wider rejig at BGI's Complete Genomics subsidiary, which is firing a "substantial" number of staff, changing CEOs and retooling to become a BGISEQ-500-focused R&D shop.

BGI is building a huge genome database to drive drug discovery

When struggling Complete Genomics went up for sale last year, it sparked a fight between rival sequencing superpowers BGI and Illumina that touched on national security and a host of other big issues. BGI ultimately won and has now begun to outline its plans for its $119 million acquisition.

BGI clears hurdle in buyout of Complete Genomics

BGI-Shenzhen nailed down U.S. government approval for its controversial buyout of Complete Genomics, which would expand the Chinese sequencing powerhouse's technological capabilities in the competitive business of decoding DNA for medicine and agriculture.

Illumina wins chance to battle Complete Genomics over patents

Illumina ($ILMN), a gene sequencer and diagnostics company, will renew a push to continue its patent fight against Complete Genomics ($GNOM).

Complete Genomics scores patent win over Illumina

Complete Genomics notched a legal victory in its patent squabble with Illumina, as a federal judge threw out 9 of Illumina's infringement claims.

China's BGI bags Complete Genomics in $117M genome-sequencing buyout

After watching its stock price get pummeled throughout the course of this year, Complete Genomics has accepted a $117 million buyout offer from China's BGI-Shenzhen. The deal comes at a 54% premium over the Mountain View, CA-based biotech's close in early June, when it announced a plan to start studying strategic options, igniting buzz about a likely takeover.

China's BGI strikes deal to buy Complete Genomics for $117.6M

Complete Genomics' ($GNOM) search for strategic alternatives announced in June has led to a $117.6 million buyout deal with DNA sequencing competitor BGI. China-based BGI plans to scoop up Moutain View, CA-based Complete for $3.15 per share in cash as part of a move that would expand the company's U.S. footprint.

Amazon tempts pharma R&D outfits with low-cost data storage

Amazon has revealed a new cloud-based service called Glacier for archiving large amounts data on the cheap.

Complete Genomics, Ingenuity combine forces to understand genomes

As interpreting DNA sequencing data becomes a focus in biotech research, Complete Genomics ($GNOM) and Ingenuity Systems plan to roll up their technologies to provide a more complete combined service to sequencing customers.

Complete Genomics axes 55 staffers

Complete Genomics is slumping. The provider of whole genome sequencing and informatics support has decided to cut about 20% of its roster to conserve cash, and the company has hired a financial adviser to aid its hunt for "strategic alternatives."